Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells

Clinical trial NCT03070002 · TERMINATED

Trial details

NCT number

NCT03070002

Sponsor

Northwestern University

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2017-10-19

Primary completion

2018-03-06

Enrollment

1

View on ClinicalTrials.gov